Excerpts

In the subgroup with a follow-up date of more than four years, patients with hypothyroidism can reduce the risk of breast cancer, with borderline significance (OR 0.96, 95% CI 0.91–1.00, P < 0.001).

The differential results displayed ( Fig 8A ) that the expression profiles of 9 hub genes in both the VS group and the control group from the combined datasets demonstrated highly significant statistical variances ( p < 0.001).

Kaplan–Meier curves revealed a significant trend toward reduced survival in the high-risk group compared to the low-risk group after 2 years ( p < 0.001, Figure 4 E).

A significantly lower proportion of patients reported use of any PPI at all subsequent postoperative follow-ups, although a slight trend towards increasing use over time was noted (1-year: 4.8%, p < 0.001; 2-years: 19.4%, p = 0.002; 3-years: 12.5%, p < 0.001; 5-years: 18.8%, p = 0.063; Fig. 2 C).

Generalized Linear Model A likelihood ratio test comparing the null and the full Generalized Linear Model was highly significant (χ 2 = 225, df = 7, P< 0.001) ( Table 5 ).

Interestingly, administration of PN, with any doses, and metformin provided a highly significant effect on the downregulation of CD36 mRNA expression ( p < 0.001) when compared to vehicle-treated DIO mice ( Figure 9D ).

Microscopic Features of the Colletotrichum Isolates A highly significant ( p < 0.001) variation was observed among the isolates concerning their conidial size (both length and width) and sporulation capacity (Table 3 ).

Pre-harvest sprouting tolerance (PHST) based on SS and FN exhibited highly significant ( p < 0.001) phenotypic differences.

EC showed highly significant concentration-dependent increases ( P < 0.001).

Statistical analysis revealed a highly significant difference between the two methods (paired t-test, p < 0.001), with the Model 1 outperforming the doctor by an average of 0.20 to 0.22 (95% CI: 0.193–0.221).

All intermediate timepoints (3, 6, and 12 months) also showed highly significant improvements compared to baseline (all p < 0.001) with stable distributions compared to 1 month (all p > 0.05) (Fig. 2 ).

The correlation coefficients ranged from moderate to very high (with r ranging from 0.6 to 0.9), all highly significant ( p < 0.001).

For adults, there were significant or marginally significant positive biases in all distances (near: t (19) = 6.52, p < 0.001; middle: t (19) = 4.67, p < 0.001; far, t (22) = 1.96, p = 0.065), which suggests that adults tended to over-estimate finger positions.

Our most striking result was a highly significant difference ( p < 0.001–0.05) in peak approaching YAV between the subjects with aUVL and healthy controls (HCs) across circumvention protocols (see Figures 3 – 5 ).

However, the correlation of the parameters was statistically highly significant ( P <0.001).

Although the effect size of PM 10 in the median regression was very small (β = − 0.002), it was highly significant ( p < 0.001).

The improvement was highly significant (Wilcoxon signed-rank test, P = 0.001), as was the improvement on TRRC (Wilcoxon signed-rank test, P = 0.001).

Median confidence increased from not at all confident to somewhat confident, a highly significant improvement (Wilcoxon z = 5.11, p < 0.001, r = 0.84).

Differences between each group were assessed by Student’s t -test, while * p < 0.05 was regarded as statistically significant, ** p < 0.01 was highly significant, and *** p < 0.001 was strongly significant.

The results revealed highly significant effects of age and sex on IE incidence (both P < .001) ( Figure 2A ).

This negative trend is highly significant ( p < 0.001).

After further division of the entire cohort by age, this difference did not reach statistical significance for patients younger than 80 years (age range, 28–79 years) ( P =0.246, Figure 2C ), but was again highly significant in the group of patients aged 80 years and older (age range, 80–99 years) ( P <0.001, Figure 2D ).

While GSH-Px showed a decreasing trend ( P < 0.001) as the transport duration increased (1.44 vs. 1.21 vs. 0.06 vs. 0.04 μmol/mg Hb for T1, T2, T3, and T4, respectively).

The high-dose treatments of ADSP (ADSP-HD) and AFP (AFP-HD) led to more pronounced reductions, with highly significant differences ( p < 0.001).

45.67 ± 8.79, 47.41 ± 10.15 and 50.86 ± 9.32 respectively) with highly significant different results ( p < 0.001).